trending Market Intelligence /marketintelligence/en/news-insights/trending/uztjxs7pgdoxnbrjfgbdkw2 content esgSubNav
In This List

Arena Pharmaceuticals plans common stock offering

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Arena Pharmaceuticals plans common stock offering

Arena Pharmaceuticals Inc. plans to sell 7.5 million of its common stock in an underwritten public offering.

The company plans to grant the underwriters an option to buy up to an additional 1,125,000 shares.

Citigroup, Leerink Partners, Cantor, Credit Suisse and RBC Capital Markets are acting as joint book-running managers, while Guggenheim Securities and JMP Securities are acting as co-managers for the offering.